Peter Schmidt - 06 Dec 2022 Form 3 Insider Report for Invivyd, Inc. (IVVD)

Role
Chief Medical Officer
Signature
/s/ Jill Andersen attorney-in-fact for Peter Schmidt
Issuer symbol
IVVD
Transactions as of
06 Dec 2022
Net transactions value
$0
Form type
3
Filing time
06 Dec 2022, 16:52:03 UTC
Next filing
16 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IVVD Common Stock 6,971 06 Dec 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IVVD Stock Option (Right to Buy) 06 Dec 2022 Common Stock 112,900 $4.61 Direct F1
holding IVVD Stock Option (Right to Buy) 06 Dec 2022 Common Stock 73,800 $6.39 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the grant date of January 13, 2021, and 1/48th of the total shares subject to the option vesting in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each vesting date.
F2 This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date of February 14, 2022, subject to the Reporting Person's continuous service as of each vesting date.

Remarks:

Exhibit 24.1: Power of Attorney